Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Cytomegalovirus infections

  • A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation
    Recruiting


  • VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
    No longer recruiting


  • IMPACT Study: A Study of Valcyte (Valganciclovir) for Prevention of Cytomegalovirus Disease (CMV) in Kidney Allograft Recipients
    No longer recruiting


  • A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients
    Completed


  • A Study of PCR-Based Pre-Emptive Therapy With Valcyte (Valganciclovir) and Ganciclovir for Cytomegalovirus (CMV) Infection After Stem Cell Transplantation
    Completed


  • A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.
    Completed


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement